Late-onset Cognitive Impairment and Modifiable Risk Factors

Survivors may be at risk of cognitive decline throughout their lives. Practitioners should consider neurocognitive surveillance for all survivors despite a lack of neurocognitive impairments after therapy. Healthcare practitioners may be able to reduce a survivor’s risk for accelerated neurocognitive decline by targeting modifiable risk factors.